BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SNCA
,
G-protein-coupled receptor binding
,
Allergy to pollen
,
Hippocampus
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
anti rheumatic drugs
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
LCN2
FOS
PTGS2
ATF3
CXCL1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
response to stress
heterocyclic compound binding
organic cyclic compound binding
regulation of nitrogen compound metabolic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
White blood cells of rheumatoid arthritis pre and post Enbrel/anti-TNF treatment
PPARg regulated gene expression in human dendritic cells
Expression Profiles in Macrophages During Maturation and Polarization
Structure and function of kidney transplant without calcineurin inhibitors
Raw264.7 macrophage gene expression profiles in reponse to paeony root-derived compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to m…
The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4⁺CD25…
Use of biological disease-modifying anti-rheumatic drugs in patients with concurrent rheumatic disea…
Old and new antirheumatic drugs and the risk of hepatotoxicity.
Defining juvenile idiopathic arthritis remission and optimum time for disease-modifying anti-rheumat…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patien…
A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With A…
An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in…
Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying An…
Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ